concept

NEUROTOXICITY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEUROTOXICITY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1236Connections

1Hypotheses

1Analyses

50Outgoing

50Incoming

0Experiments

Summary

NEUROTOXICITY is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, associated with. Associated with ALS, Aging, Als. Connected to 676 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info

Name	NEUROTOXICITY
Summary	Comprehensive analysis of homocysteine's role in neurodegenerative diseases including mechanisms of neurotoxicity, vascular effects, and therapeutic implications
Key Genes/Proteins	NEUROINFLAMMATION, NEURODEGENERATION, MICROGLIA, OXIDATIVE STRESS, ALZHEIMER'S DISEASE, ALZHEIMER
Related Diseases	Inflammation, Als, Neuroinflammation, Neurodegeneration, Alzheimer
Related Pathways	Autophagy, Oxidative Stress, Apoptosis
Linked Hypotheses	1 hypotheses

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

→

Corticobasal Syndrome (CBS)

disease · 11374 words

→

Parkinson's Disease

disease · 8807 words

→

Pathway Diagram

graph TD
    NEUROTOXICITY["NEUROTOXICITY"]
    NEUROTOXICITY -->|"activates"| Inflammation["Inflammation"]
    NEUROTOXICITY -->|"activates"| Als["Als"]
    NEUROTOXICITY -->|"activates"| Neuroinflammation["Neuroinflammation"]
    NEUROTOXICITY -->|"inhibits"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
    NEUROTOXICITY -->|"inhibits"| Dementia["Dementia"]
    NEUROTOXICITY -->|"activates"| Parkinson["Parkinson"]
    NEUROTOXICITY -->|"activates"| Ms["Ms"]
    NEUROTOXICITY -->|"activates"| Neurodegeneration["Neurodegeneration"]
    SNCA["SNCA"] -->|"causes"| NEUROTOXICITY
    complement["complement"] -->|"activates"| NEUROTOXICITY
    PI3K_AKT["PI3K-AKT"] -->|"regulates"| NEUROTOXICITY
    catalase_mRNA["catalase mRNA"] -.protects against.-> NEUROTOXICITY
    impaired_autophagic_flux["impaired autophagic flux"] -->|"causes"| NEUROTOXICITY
    P62["P62"] -->|"inhibits"| NEUROTOXICITY
    DDX3X["DDX3X"] -->|"activates"| NEUROTOXICITY
    AMYOTROPHIC_LATERAL_SCLEROSIS["AMYOTROPHIC LATERAL SCLEROSIS"] -->|"inhibits"| NEUROTOXICITY
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| NEUROTOXICITY
    NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| NEUROTOXICITY

Outgoing (799)

Target	Relation	Type	Str
NEUROINFLAMMATION	activates	gene	1.00
Inflammation	activates	disease	1.00
Als	activates	disease	1.00
Neuroinflammation	activates	disease	1.00
Neurodegeneration	activates	disease	1.00
Autophagy	activates	pathway	1.00
Alzheimer	activates	disease	1.00
Neurodegeneration	associated_with	disease	1.00
Oxidative Stress	activates	pathway	1.00
Apoptosis	activates	pathway	1.00
NEURODEGENERATION	activates	gene	1.00
MICROGLIA	activates	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
ALZHEIMER	activates	gene	1.00
Als	therapeutic_target	disease	1.00
APOPTOSIS	activates	gene	1.00
NEURODEGENERATIVE DISEASES	activates	gene	1.00
PARKINSON'S DISEASE	therapeutic_target	gene	1.00
PARKINSON	therapeutic_target	gene	1.00
Parkinson	therapeutic_target	disease	1.00
Aging	therapeutic_target	disease	1.00
Inflammation	therapeutic_target	disease	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
ALZHEIMER	therapeutic_target	gene	1.00
ALZHEIMER'S DISEASE	therapeutic_target	gene	1.00
Neurodegeneration	therapeutic_target	disease	1.00
Alzheimer	therapeutic_target	disease	1.00
CYTOKINES	activates	gene	1.00
AUTOPHAGY	activates	gene	1.00
Nf-Κb	activates	pathway	1.00
NEURODEGENERATION	associated_with	gene	1.00
NEURODEGENERATIVE DISEASES	therapeutic_target	gene	1.00
Neuroinflammation	therapeutic_target	disease	0.95
AMPK	activates	gene	0.90
TNF-Α	activates	gene	0.90
Ferroptosis	activates	pathway	0.90
Mtor	activates	pathway	0.90
TAU	activates	gene	0.90
NF-ΚB	activates	gene	0.90
MTOR	activates	gene	0.90
NEURON	activates	gene	0.90
AMYLOID	activates	gene	0.90
PARKINSON'S DISEASE	activates	gene	0.90
NEUROINFLAMMATION	therapeutic_target	gene	0.90
OXIDATIVE STRESS	therapeutic_target	gene	0.90
Oxidative Stress	therapeutic_target	pathway	0.90
NRF2	activates	gene	0.90
Parkinson	activates	disease	0.85
Aging	activates	disease	0.85

Incoming (437)

Source	Relation	Type	Str
ROS	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
Sevoflurane	causes	drug	0.95
LiCl	causes	compound	0.95
Nanoparticles	causes	compound	0.95
Methamphetamine	causes	drug	0.95
Ion Imbalance	causes	process	0.90
Excitotoxicity	causes	process	0.90
Reactive Astrocytes	mediates	cell_type	0.90
MUTANT SOD1	causes	protein	0.90
Silver Nanoparticles	causes	compound	0.90
Titanium Dioxide Nanoparticles	causes	compound	0.90
lithium chloride	causes	drug	0.90
PKN1-N207	contributes_to	protein	0.90
SNCA	causes	gene	0.90
Oxidative Stress	causes	process	0.90
AUTOPHAGY	activates	gene	0.90
Iron Overload	causes	phenotype	0.88
BPA	causes	drug	0.88
Gasdermin D	mediates	protein	0.85
mtDNA damage	contributes_to	phenotype	0.85
Microglia	mediates	cell_type	0.85
Neuroinflammation	contributes_to	process	0.85
TP53	associated_with	gene	0.80
Beta-Amyloid	causes	protein	0.80
Microglia	contributes_to	cell_type	0.80
MITOPHAGY	activates	gene	0.80
APOPTOSIS	therapeutic_target	gene	0.80
complement	activates	protein	0.70
autophagy	associated_with	process	0.70
catalase mRNA	protects_against	drug	0.70
impaired autophagic flux	causes	process	0.70
oligomers	promotes	protein	0.70
Zn	treats	drug	0.70
PI3K-AKT	regulates	pathway	0.70
NEURODEGENERATION	activates	gene	0.70
INFLAMMATION	activates	gene	0.70
TAU	activates	gene	0.70
AUTOPHAGY	regulates	gene	0.70
APOPTOSIS	regulates	gene	0.70
MYELIN	activates	gene	0.70
NLRP3	activates	gene	0.70
KEAP1	activates	gene	0.70
GSDMD	activates	gene	0.70
ERK	activates	gene	0.70
NEURODEGENERATION	causes	gene	0.70
mitophagy	prevents	process	0.70
P62	inhibits	gene	0.60
RAN	associated_with	gene	0.60
DDX3X	activates	gene	0.60

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxici	0.609	neurodegeneration	Should microtubule-stabilizing drugs be

Mentioning Analyses (1)

Scientific analyses that reference this entity

Systemic immune profiling and peripheral immune contributions to neurodegenerati

neurodegeneration | 2026-04-04 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

NEUROTOXICITY

Understanding Entity Pages

Summary

Wiki Pages (21)

Homocysteine Neurotoxicity and Neurodegeneration

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Corticobasal Syndrome (CBS)

Parkinson's Disease

Sleep and Circadian Dysfunction in Alzheimer's Disease

Parthanatos in Neurodegeneration

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Myoclonus and Cortical Hyperexcitability in Corticobasal Syndrome

nimodipine-als

Section 162: Advanced Antioxidant and Redox Therapy in CBS/PSP

neuroinflammation

NRF2 Oxidative Stress Pathway

Microglial Cells — Cell Type Hierarchy

Astrocyte Reactivity Mechanism

rasagiline

Tau Spreading Mechanism

oxidative-stress-comparison

APOC4 — Apolipoprotein C-IV

Wnt Non-Canonical Signaling Pathways in Neurodegeneration